Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Cellcept, Myfortic can lead to Miscarriages, Birth Defects

The Food and Drug Administration has warned that Roche and Novartis may lead to miscarriages or birth defects when used by pregnant women. The drugs are commonly used for organ transplant patients, and the FDA has received reports of these health risks, prompting the warning. The immune suppression drugs, Roche's CellCept, and Novartis AG drug Myfortic, are used to avoid organ rejection, and last October received the FDA's most serious warning. The FDA will continue to work with the drugs' manufacturers to curb its use in women who are pregnant, or might become pregnant.

Legal Help

If you or a loved one has suffered miscarriages or birth defects while taking these drugs, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.
Published on May-21-08


ADD YOUR COMMENT ON THIS ISSUE

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Legal Help Now! - Free